ASH: Hematology

Latest ASH: Hematology News

Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimetic

SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable

Derick Alison Derick Alison

Ibrutinib-Venetoclax Improves PFS in R/R Mantle Cell Lymphoma

SAN DIEGO -- Patients with relapsed/refractory mantle cell lymphoma (MCL) lived significantly

Derick Alison Derick Alison

‘Half-Matched’ BMTs Effective in Severe Sickle Cell Disease

SAN DIEGO -- A reduced-intensity "half-matched" bone marrow transplant (BMT) protocol demonstrated

Derick Alison Derick Alison

Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder

SAN DIEGO -- In a randomized trial, pomalidomide (Pomalyst) significantly reduced severe

Derick Alison Derick Alison

Four Drugs Top Three for Upfront Treatment of Multiple Myeloma

SAN DIEGO -- Patients with newly diagnosed multiple myeloma had almost a

Derick Alison Derick Alison

Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia

SAN DIEGO -- Nearly two-thirds of patients with relapsed or refractory KMT2A-rearranged

Derick Alison Derick Alison

Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B

SAN DIEGO -- The investigational monoclonal antibody marstacimab reduced the rate of

Derick Alison Derick Alison

Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosis

SAN DIEGO -- Combining the Janus kinase (JAK) inhibitor ruxolitinib (Jakafi) with

Derick Alison Derick Alison

Axatilimab Shows Efficacy in Recurrent/Refractory GVHD

SAN DIEGO -- Axatilimab achieved rapid and durable responses in patients with

Derick Alison Derick Alison

MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia

SAN DIEGO -- Measurable residual disease (MRD) after induction therapy can guide

Derick Alison Derick Alison
adbanner